Farallon Capital Management LLC Iovance Biotherapeutics, Inc. Transaction History

Farallon Capital Management LLC

$19.9 Billion
Q3 2024

A detailed history of Farallon Capital Management LLC transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Farallon Capital Management LLC holds 26,000 shares of IOVA stock, worth $191,880. This represents 0.0% of its overall portfolio holdings.

Number of Shares

26,000

Previous 26,000 -0.0%

Holding current value

$191,880

Previous $208,000 17.31%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$7.59 - $17.47 $4.07 Million - $9.36 Million	-536,000 Reduced 95.37%	26,000 $385,000
Q4 2023 Feb 14, 2024	BUY	$3.3 - $8.89 $1.85 Million - $5 Million	562,000 New	562,000 $4.57 Million
Q2 2022 Aug 15, 2022	SELL	$6.38 - $18.33 $19.1 Million - $55 Million	-2,998,584 Reduced 48.56%	3,176,773 $35.1 Million
Q1 2022 May 16, 2022	BUY	$12.38 - $19.1 $1.4 Million - $2.17 Million	113,384 Added 1.87%	6,175,357 $103 Million
Q4 2021 Feb 14, 2022	BUY	$16.55 - $27.63 $11.9 Million - $19.9 Million	721,979 Added 13.52%	6,061,973 $116 Million
Q3 2021 Nov 15, 2021	BUY	$20.35 - $26.63 $1.83 Million - $2.4 Million	89,994 Added 1.71%	5,339,994 $132 Million
Q2 2021 Aug 13, 2021	BUY	$16.33 - $33.07 $8.16 Million - $16.5 Million	500,000 Added 10.53%	5,250,000 $137 Million
Q1 2021 May 17, 2021	SELL	$28.67 - $52.59 $35.8 Million - $65.7 Million	-1,250,000 Reduced 20.83%	4,750,000 $150 Million
Q4 2020 Feb 16, 2021	BUY	$28.04 - $50.26 $1.26 Million - $2.26 Million	45,000 Added 0.76%	6,000,000 $278 Million
Q3 2020 Nov 16, 2020	SELL	$27.75 - $36.3 $16.2 Million - $21.1 Million	-582,500 Reduced 8.91%	5,955,000 $196 Million
Q2 2020 Aug 14, 2020	BUY	$27.21 - $41.0 $21.4 Million - $32.3 Million	787,500 Added 13.7%	6,537,500 $179 Million
Q1 2020 May 15, 2020	SELL	$19.54 - $38.85 $9.77 Million - $19.4 Million	-500,000 Reduced 8.0%	5,750,000 $172 Million
Q4 2019 Feb 13, 2020	BUY	$17.95 - $29.41 $4.04 Million - $6.62 Million	225,000 Added 3.73%	6,250,000 $173 Million
Q3 2019 Nov 14, 2019	BUY	$17.99 - $26.0 $5.4 Million - $7.8 Million	300,000 Added 5.24%	6,025,000 $110 Million
Q4 2018 Feb 14, 2019	BUY	$7.51 - $11.93 $7.51 Million - $11.9 Million	1,000,000 Added 21.16%	5,725,000 $50.7 Million
Q3 2018 Nov 14, 2018	BUY	$11.25 - $17.7 $3.38 Million - $5.31 Million	300,000 Added 6.78%	4,725,000 $53.2 Million
Q2 2018 Aug 14, 2018	BUY	$12.45 - $16.95 $3.42 Million - $4.66 Million	275,000 Added 6.63%	4,425,000 $56.6 Million
Q1 2018 May 15, 2018	BUY	$8.1 - $19.5 $18.5 Million - $44.5 Million	2,283,100 Added 122.29%	4,150,000 $70.1 Million
Q4 2017 Feb 14, 2018	BUY	$6.65 - $9.25 $6.76 Million - $9.41 Million	1,016,900 Added 119.64%	1,866,900 $14.9 Million
Q3 2017 Nov 14, 2017	BUY	$4.45 - $8.55 $3.78 Million - $7.27 Million	850,000	850,000 $6.59 Million

Others Institutions Holding IOVA

# of Institutions

313

Shares Held

237M

Call Options Held

3.77M

Put Options Held

1.7M

View Full List

About IOVANCE BIOTHERAPEUTICS, INC.

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.16B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

More about IOVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Farallon Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Farallon Capital Management LLC with notifications on news.

Account

Farallon Capital Management LLC Iovance Biotherapeutics, Inc. Transaction History